VBI Vaccines recalls hepatitis B shot as it winds down operations

Months after filing for bankruptcy, VBI Vaccines is taking the next step in shuttering operations with the voluntarily withdrawal of its hepatitis B vaccine, PreHevbrio.

The company alerted healthcare providers and the FDA that it would be looking to pull PreHevbrio last month.